{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:45:38Z","timestamp":1790801138777,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jpeds.2008.09.021","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T08:26:11Z","timestamp":1225527971000},"page":"379-384.e2","source":"Crossref","is-referenced-by-count":229,"title":["Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung Disease"],"prefix":"10.1016","volume":"154","author":[{"given":"Peter M.","family":"Mourani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marci K.","family":"Sontag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Dunbar","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Abman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2008.09.021_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ppul.1950090306","article-title":"Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease","volume":"9","author":"Hislop","year":"1990","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib2","series-title":"Diagnosis and treatment of pulmonary hypertension","first-page":"155","article-title":"Pulmonary circulation and cardiovascular sequelae of BPD","author":"Abman","year":"1992"},{"key":"10.1016\/j.jpeds.2008.09.021_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3476(88)80125-2","article-title":"Pulmonary hypertension in infants with bronchopulmonary dysplasia","volume":"112","author":"Goodman","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2008.09.021_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpedsurg.2003.11.010","article-title":"The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia","volume":"39","author":"Dillon","year":"2004","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpeds.2008.09.021_bib5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.2007-0971","article-title":"Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era","volume":"120","author":"Khemani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2008.09.021_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn","volume":"342","author":"Clark","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1203\/00006450-198808000-00009","article-title":"Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension","volume":"24","author":"Brownlee","year":"1988","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2008.09.021_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/rccm.200310-1483OC","article-title":"Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia","volume":"170","author":"Mourani","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2008.09.021_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2008.09.021_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","article-title":"Sitaxsentan therapy for pulmonary arterial hypertension","volume":"169","author":"Barst","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/oxfordjournals.eurheartj.a015478","article-title":"An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension","volume":"18","author":"Mikhail","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2008.09.021_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003495-200464070-00009","article-title":"Inhaled iloprost: in primary pulmonary hypertension","volume":"64","author":"Goldsmith","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jpeds.2008.09.021_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0002-9149(03)00910-X","article-title":"Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension","volume":"92","author":"Ivy","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1378\/chest.109.6.1545","article-title":"Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests","volume":"109","author":"Channick","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.jpeds.2008.09.021_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000101343","article-title":"Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn","volume":"91","author":"Abman","year":"2007","journal-title":"Neonatology"},{"key":"10.1016\/j.jpeds.2008.09.021_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccm.2006.12.002","article-title":"The nitric oxide\/cGMP signaling pathway in pulmonary hypertension","volume":"28","author":"Klinger","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3565(25)24870-4","article-title":"Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid","volume":"237","author":"Ignarro","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpeds.2008.09.021_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1164\/ajrccm.158.1.9711042","article-title":"Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message","volume":"158","author":"Hanson","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib25","doi-asserted-by":"crossref","first-page":"L727","DOI":"10.1152\/ajplung.00409.2004","article-title":"Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus","volume":"288","author":"Deruelle","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ehj.2004.01.013","article-title":"Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects","volume":"25","author":"Mikhail","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpeds.2008.09.021_bib27","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200210-1157BC","article-title":"Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension","volume":"167","author":"Ghofrani","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib28","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Michelakis","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2008.09.021_bib29","first-page":"404","article-title":"Chronic oral sildenafil therapy in severe pulmonary artery hypertension","volume":"54","author":"Kothari","year":"2002","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jpeds.2008.09.021_bib30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study","volume":"43","author":"Sastry","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib31","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2008.09.021_bib33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/78.10.1207","article-title":"Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy","volume":"78","author":"Bhatia","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpeds.2008.09.021_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/peds.2007-1583","article-title":"Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease","volume":"121","author":"Mourani","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2008.09.021_bib35","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","article-title":"Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study","volume":"111","author":"Humpl","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2008.09.021_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005494.pub2","article-title":"Sildenafil for pulmonary hypertension in neonates","author":"Shah","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2008.09.021_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000097125","article-title":"Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension","volume":"91","author":"Noori","year":"2007","journal-title":"Neonatology"},{"key":"10.1016\/j.jpeds.2008.09.021_bib38","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s00134-003-2016-4","article-title":"Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery","volume":"29","author":"Stocker","year":"2003","journal-title":"Intensive Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2008.09.021_bib39","first-page":"167","article-title":"Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease","volume":"108","author":"Schulze-Neick","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2008.09.021_bib40","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","article-title":"Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children","volume":"174","author":"Namachivayam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2008.09.021_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpeds.2007.11.006","article-title":"Left ventricular diastolic dysfunction in bronchopulmonary dysplasia","volume":"152","author":"Mourani","year":"2008","journal-title":"J Pediatr"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347608007853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347608007853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T13:16:36Z","timestamp":1738502196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347608007853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0022347608007853"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2008.09.021","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}